Pregnancy Exposures and Outcomes in Women with Psoriasis Treated with Risankizumab: A Cohort Study Utilizing Large Electronic Healthcare Databases with Mother-Baby Linkage in the United States

First published 16/03/2021

Last updated 14/03/2024

EU PAS number:

EUPAS39775

Study

Ongoing

Documents

Study protocol

Initial protocol

p16751-protocol-pmos abstract-18oct2020_Redacted

English (177.15 KB - PDF)View document

Updated protocol

riskmgtsystem-pam-p16751-protocol-pmos_v1.4_abstract_Redacted

First published: 22/02/2024

English (150.93 KB - PDF)View document

Study results

Study report

Other information

ENCePP Seal

ENCePP Seal documents

Secondary tabs